Evaluation of dual pathogen recognition receptor agonists as adjuvants for respiratory syncytial virus – virus-like particles for pulmonary delivery
IntroductionRespiratory syncytial virus (RSV) remains a significant global health concern, particularly for infants and young children in developing countries. Despite ongoing research efforts, an effective RSV vaccine has yet to be approved for widesp…